Leber Hereditary Optic Neuropathy (LHON) is a rare but serious inherited eye disorder that leads to sudden, painless vision loss. Unlike common eye diseases, LHON primarily affects the optic nerve due to mutations in mitochondrial DNA. This condition usually begins in young adulthood, especially among men, but it can occur at any age.
Although LHON is rare, it is one of the most common inherited optic neuropathies, with an estimated prevalence of 1 in 30,000–50,000 people worldwide. Early recognition and management are crucial to prevent permanent visual disability and improve quality of life.
Leber Hereditary Optic Neuropathy (LHON) is a mitochondrial genetic disorder where mutations affect energy production in retinal ganglion cells. Because the optic nerve relies heavily on mitochondrial function, it becomes damaged, leading to central vision loss.
Unlike many genetic conditions, LHON is maternally inherited, meaning it passes through the mother, even if she shows no symptoms.
Causes of LHON
The root cause of LHON lies in mutations in mitochondrial DNA (mtDNA). The most common mutations are:
- m.11778G>A (ND4 gene) → Found in about 70% of LHON cases worldwide.
- m.14484T>C (ND6 gene) → Often associated with better visual recovery.
- m.3460G>A (ND1 gene) → Less common, but linked to more severe disease.
Risk Factors That Can Trigger Vision Loss
Not everyone carrying an LHON mutation develops symptoms. Environmental and lifestyle factors can increase risk, such as:
- Smoking
- Heavy alcohol consumption
- Certain medications (e.g., anti-tuberculosis drugs, antiretrovirals)
- Nutritional deficiencies
Symptoms of LHON
LHON typically starts with sudden, painless vision loss in one eye, followed by the other eye within weeks or months.
Common Symptoms
- Central vision loss (blurred or dark spot in the centre of vision)
- Difficulty recognising faces
- Problems with reading and fine detail
- Colour vision abnormalities (especially red-green deficiency)
- Reduced contrast sensitivity
Did You Know? Around 90% of men and 10% of women with a pathogenic LHON mutation eventually develop vision loss
Stages of Vision Loss in LHON
|
Stage |
Description |
Timeline |
|
Asymptomatic |
Carriers have genetic mutations but normal vision. |
Anytime before onset |
|
Acute Phase |
Sudden central vision loss in one eye, spreading to the other. |
Weeks to months |
|
Subacute |
Progressive worsening of vision. |
3–6 months |
|
Chronic Phase |
Permanent optic atrophy and central blindness. |
>6 months |
How is LHON Diagnosed?
Diagnosing LHON requires a combination of clinical assessment and genetic testing.
Key Diagnostic Steps
- Medical & Family History – Sudden vision loss in young men with maternal history raises suspicion.
- Eye Examination – Optic disc swelling (early stage) or optic atrophy (later stage).
- Visual Field Testing – Detects central or cecocentral scotoma.
- Optical Coherence Tomography (OCT) – Shows thinning of the retinal nerve fibre layer.
- Genetic Testing – Confirms mutations in mtDNA.
Treatment Options for LHON
Currently, there is no universal cure for LHON, but several treatment and management strategies exist.
1. Medical Treatment
- Idebenone (Raxone®): The only approved drug in Europe, shown to improve visual outcomes in some patients.
- EPI-743 (Vincerinone): An experimental antioxidant therapy.
- Nutritional Supplements: Coenzyme Q10, vitamin B-complex, and antioxidants may support mitochondrial function.
2. Gene Therapy
- Lenadogene nolparvovec (Lumevoq®) is under clinical trials and has shown promising results in improving visual recovery by delivering functional ND4 gene copies.
3. Supportive Management
- Low-vision aids (magnifiers, text-to-speech software)
- Lifestyle modification (avoid smoking & alcohol)
- Genetic counselling for families
Prognosis of LHON
- m.14484T>C mutation carriers have the best chance of spontaneous recovery (up to 37% recover some vision).
- m.11778G>A mutation carriers rarely experience significant recovery (<15%).
- Women generally have a milder disease course compared to men.
Living with LHON: Patient Support
- Support groups and charities (e.g., LHON Society UK, UMDF) help patients connect.
- Rehabilitation services provide training in mobility and assistive technology.
Quick Facts Box
- LHON is the most common inherited optic neuropathy.
- Affects men 4–5 times more than women.
- Vision loss usually begins between 15–35 years of age.
- Smoking increases risk of disease expression by up to 3x.
FAQs About LHON
Here are some frequently asked questions about LHON:
1. Can LHON be cured?
Currently, there is no permanent cure, but treatments such as Idebenone and gene therapy trials show potential in improving visual outcomes.
2. Is LHON always inherited from the mother?
Yes. LHON is caused by mutations in mitochondrial DNA, which is passed only through the maternal line.
3. Can carriers of LHON mutations remain symptom-free?
Yes. Many carriers never develop symptoms, but lifestyle factors like smoking and alcohol may trigger disease expression.
4. How fast does vision loss occur in LHON?
Vision loss usually starts in one eye and progresses to the other within weeks to months.
Conclusion
Leber Hereditary Optic Neuropathy (LHON) is a rare but devastating genetic condition that leads to vision loss, especially in young men. While there is currently no cure, advances in gene therapy and antioxidants offer hope for the future. Early diagnosis, genetic testing, and lifestyle modifications remain essential in reducing risk and improving quality of life.
If you or a family member experiences sudden unexplained vision loss, consult an eye care professional immediately.
The latest research and updates straight to your inbox !
Join our subscribers for exclusive access to our monthly newsletter related to optometry
